$PIRS granted US Patent #10865250 for "Anti-cancer fusion polypeptide". For the treatment/prevention of a variety of tumors. No Press Release Yet.https://t.co/fg9RdtYSKJ
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.